RT MicroDx is reshaping the healthcare landscape by developing accurate, affordable, at-home molecular testing solutions that empower individuals, alleviate financial distress, and contribute to healthier communities worldwide. Our readerless RT LAMP reaction, utilizing saliva samples, empowers individuals and families to take control of their health journey from the comfort of their homes. 
 
Leveraging our scalable testing platform, we are currently developing the first over-the-counter, molecular-based, at-home test for strep, the “RST,” offering a simplistic yet robust and inexpensive testing solution that only requires a saliva sample rather than a painful and invasive throat swab. With accuracy levels reaching 97% specificity and 99% sensitivity, our solutions transcend traditional at-home testing barriers, offering timely and reliable results.


Health Diagnostics

mHealth

Health Care

Medical Devices

RT MicroDx

Org chart

Teams

Similar companies